iNova Pharmaceuticals Executive and Leadership Team

William Foo, the Group Chief Financial Officer at iNova Pharmaceuticals, manages the company's financial health and strategic fiscal planning. Overseeing all financial operations, Foo ensures robust financial reporting, capital allocation, and investment strategies that align with iNova's expansion across Asia, Australia and New Zealand, and Africa. This critical position involves managing budgets, forecasting financial performance, and identifying opportunities for fiscal optimization to support the development and sale of prescription medicines and consumer health products. By maintaining strong financial discipline, William Foo directly supports the company's long-term sustainability and its capacity to innovate. Foo's expertise is vital for navigating complex international financial landscapes and driving profitable growth.

Paul Smith, the Chief Operating Officer at iNova Pharmaceuticals, directs the operational execution of the company's global strategy. Overseeing day-to-day business activities, Smith ensures efficient product development, manufacturing, and distribution channels across iNova's diverse markets in Asia, Australia and New Zealand, and Africa. This leadership role involves optimizing supply chain logistics and enhancing internal processes to support the company's mission of delivering high-quality pharmaceutical and consumer health products. By driving operational excellence, Paul Smith directly contributes to the company's market presence and its ability to meet consumer health needs effectively. Smith's focus remains on scaling operations to support continued growth and market penetration in key regions.

Sacha Ernst, the President (Asia) at iNova Pharmaceuticals, leads the company's strategic direction and operational oversight throughout the Asian market. Directing all business activities within this key region, Ernst focuses on expanding iNova's footprint in developing and selling prescription medicines and consumer health products. This leadership position involves fostering strong relationships with local stakeholders, navigating diverse market dynamics, and ensuring alignment with the company's global mission. By driving regional growth, Sacha Ernst directly contributes to iNova's overall market presence and its ability to serve Asian consumers effectively. Ernst's strategic vision is crucial for capitalizing on emerging opportunities and strengthening iNova's position in Asia.

Andrew Jenkin, the President, , Zealand (Canada, Australia) at iNova Pharmaceuticals, directs the company's strategic operations and market development across Canada, Australia, and New Zealand. Overseeing all commercial activities in these significant territories, Jenkin focuses on enhancing the reach and impact of iNova's prescription medicines and consumer health products. This role involves adapting global strategies to local market conditions, fostering key partnerships, and ensuring the effective delivery of health solutions to diverse populations. By driving regional performance, Andrew Jenkin directly contributes to iNova's international growth and its commitment to improving health outcomes. Jenkin's leadership is pivotal in navigating the unique challenges and opportunities within these key markets.

Johan Rempel, the President at iNova Pharmaceuticals, provides overarching leadership and strategic direction for the company's global operations. Directing key initiatives, Rempel ensures the successful development, marketing, and sale of a wide range of prescription medicines and consumer health products across iNova's extensive international markets. This vital role involves fostering a culture of innovation and excellence, guiding cross-functional teams, and making critical decisions that support the company's mission to enhance health and well-being. By driving strategic growth and operational efficiency, Johan Rempel directly contributes to iNova's sustained success and its ability to meet evolving healthcare needs worldwide. Rempel's leadership is instrumental in navigating complex global landscapes and achieving ambitious corporate objectives.

Omar Mahmoud, the Chief Marketing Officer, Commercial Quality, MENA at iNova Pharmaceuticals, spearheads marketing initiatives and ensures commercial quality standards within the Middle East and North Africa region. Directing all marketing strategies, Mahmoud focuses on enhancing brand visibility and market penetration for iNova's extensive portfolio of prescription medicines and consumer health products. This role involves developing targeted campaigns that resonate with regional consumer needs and regulatory requirements, while upholding stringent quality benchmarks. By driving commercial success, Omar Mahmoud directly contributes to iNova's growth and reputation in the MENA market. Mahmoud's leadership ensures that marketing efforts are both impactful and compliant, supporting the company's overall business objectives.